Back in December, the University of Kansas issued a public censure of a former water researcher who, the school says, engaged in a pattern of plagiarism and other shoddy publishing practices.
Marios Sophocleous, who’d held the position of senior scientist at the Kansas Geological Survey:
Continue reading Retractions appear in case of former Kansas water scientist rebuked for misconduct
In December, a group of biologists in Thailand published a paper in the Nordic Journal of Botany heralding the discovery of a new species of plant:
Bauhinia saksuwaniae, a new species from northeastern Thailand is described and illustrated. It appears to be an endemic and endangered species. The new species is obviously distinct from all other species of Thai Bauhinia in having large orbicular persistent bracteoles forming a cup-shape and enclosing a young floral bud.
But then came this retraction: Continue reading Plant paper retracted when new species turns out not to be so new
Almost two years ago, we brought you — with the help of Trevor Stokes — the story of a stem cell researcher in Korea whose publication record, and career, unraveled after evidence of image manipulation surfaced in her work.
We’ve reported on four retractions, all in Antioxidants & Redox Signaling, by Soo-Kyung Kang, formerly of Seoul National University resulting from the efforts of a whistleblower. There has been another in Human Gene Therapy: Continue reading Stem cell researcher in Korea up to half a dozen retractions
A group of authors in South Korea has lost their 2012 paper in Clinical Cardiology because, well, they weren’t a group after all.
The paper, “Correlation of Electrocardiographic Changes and Myocardial Fibrosis in Patients With Hypertrophic Cardiomyopathy Detected by Cardiac Magnetic Resonance Imaging,” came from corresponding author Hyun Suk Yang, of Konkuk University School of Medicine in Seoul, and a half-dozen colleagues. At least, that’s what the manuscript said.
But according to the retraction notice, Yang had nothing to do with the paper — nor did five other co-authors. Continue reading Heart study retracted because it was submitted without permission of most of the authors
International Studies Quarterly, a Wiley title, is retracting a paper because — oops! — it published the same article twice, unbeknownst to the authors.
Here’s the notice: Continue reading Double taxation: Journal retracts paper it published twice
Ulrich Lichtenthaler, the management professor who has had 13 papers retracted, has a correction in the Journal of Product Innovation Management.
Here’s the text of the correction for “The Role of Champions in the External Commercialization of Knowledge, ” which is followed by the corrected tables: Continue reading Erratum appears for Ulrich Lichtenthaler, who has 13 retractions
In a case whose irony is not lost on those involved, an article about publishing ethics has been retracted because one of the authors re-used material he’d written for an earlier piece. But the authors and the journal’s editors have turned the episode into a learning opportunity.
Here’s the notice for “Ethics and Integrity of the Publishing Process: Myths, Facts, and a Roadmap,” published in 2011 by Marshall Schminke and Maureen L. Ambrose: Continue reading Oh, the irony: Paper on “Ethics and Integrity of the Publishing Process” retracted for duplication
A suggestion: When you title your paper “Joined at the hip?”, better make sure it’s not too close for comfort to someone else’s work.
Alas, an Idaho anthropologist failed to heed that lesson when she published “Joined at the hip? A paleoepidemiological study of developmental dysplasia of the hip and its relation to swaddling practices among indigenous peoples of North America,” in the American Journal of Human Biology last October.
The article, by Samantha Blatt, of Boise State University, found that: Continue reading Hip disjoint: Dysplasia paper lacks proper attribution, earns retraction
A group of researchers from MD Anderson Cancer Center in Houston has lost a 2013 paper in BJU International for running afoul of their institution’s ethics review board, and of military reviewers, as well.
The paper, “Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance,” looked at prostate cancer screening in men 55 and under — considered young for the older-man’s disease. According to the abstract: Continue reading IRB mishap costs MD Anderson team a paper on prostate cancer
Cancer Science, the journal of the Japanese Cancer Association, has retracted a 2012 article by a group of researchers because, well, it wasn’t clear who made up the group in the first place.
The article, “Antitumor activity of human γδ T cells transducted with CD8 and with T-cell receptors of tumor-specific cytotoxic T lymphocytes,” appeared online in July 2012 and was written, ostensibly, by Takeshi Hanagiri, Yoshiki Shigematsu, Koji Kuroda, Tetsuro Baba, Hironobu Shiota, Yoshinobu Ichiki, Yoshika Nagata, Manabu Yasuda, Tomoko So, Mitsuhiro Takenoyama and Fumihiro Tanaka from the Second Department of Surgery at the University of Occupational and Environmental Health, in Kitakyushu.
The abstract states: Continue reading Dispute with “unlisted author whose claim to authorship could not be solved” topples cancer paper